Ai-assisted detection of lymph node metastases safely reduces costs and time

Our non-randomized single-center clinical trial demonstrates the safety, cost-saving and time-saving potential of artificial intelligence (AI) assistance in the detection of breast cancer

metastases in sentinel lymph nodes. AI assistance shows important benefits for pathologists and the laboratory workflow, which are needed as cancer incidence and diagnostics continue to

rise. Access through your institution Buy or subscribe This is a preview of subscription content, access via your institution ACCESS OPTIONS Access through your institution Access Nature and

54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription $29.99 / 30 days cancel any time Learn more Subscribe to this journal Receive 12 digital issues and

online access to articles $119.00 per year only $9.92 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to

local taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support REFERENCES *

Andersson, Y., Frisell, J., Sylvan, M., de Boniface, J. & Bergkvist, L. Breast cancer survival in relation to the metastatic tumor burden in axillary lymph nodes. _J. Clin. Oncol._ 28,

2868–2873 (2010). THIS STUDY DEMONSTRATES A WORSE PROGNOSIS FOR PATIENTS WITH MICROMETASTASES THAN FOR PATIENTS WHO ARE NODE-NEGATIVE. Article  PubMed  Google Scholar  * Flach, R. N. et al.

CONFIDENT-trial protocol: a pragmatic template for clinical implementation of artificial intelligence assistance in pathology. _BMJ Open_ 13, e067437 (2023). THIS PAPER REPORTS THE

CONFIDENT-TRIAL PROTOCOL, PROVIDING A PRAGMATIC TEMPLATE FOR CLINICAL IMPLEMENTATION OF AI-ASSISTANCE IN PATHOLOGY. Article  PubMed  PubMed Central  Google Scholar  Download references

ADDITIONAL INFORMATION PUBLISHER’S NOTE Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. THIS IS A SUMMARY OF: van

Dooijeweert, C. et al. Clinical implementation of artificial-intelligence-assisted detection of breast cancer metastases in sentinel lymph nodes: the CONFIDENT-B single-center,

non-randomized clinical trial. _Nat. Cancer_ https://doi.org/10.1038/s43018-024-00788-z (2024). RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE

AI-assisted detection of lymph node metastases safely reduces costs and time. _Nat Cancer_ 5, 1139–1140 (2024). https://doi.org/10.1038/s43018-024-00795-0 Download citation * Published: 24

July 2024 * Issue Date: August 2024 * DOI: https://doi.org/10.1038/s43018-024-00795-0 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get

shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative